Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Sep;67(1):23–32.

A comparison of the antianaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue

PR Butchers, JR Fullarton, IF Skidmore, LE Thompson, CJ Vardey, A Wheeldon
PMCID: PMC2043613  PMID: 115530

Abstract

1 Salbutamol and disodium cromoglycate were compared for anti-anaphylactic activity against passive anaphylaxis in rat skin and peritoneum in vivo and in rat mast cells and human lung fragments in vitro.

2 Salbutamol administered intravenously to rats inhibited cutaneous anaphylaxis, but also inhibited cutaneous responses to histamine and 5-hydroxytryptamine. Salbutamol administered intraperitoneally inhibited the release of slow reacting substance of anaphylaxis (SRS-A) but not the release of histamine in the peritoneum. It was a very weak inhibitor of histamine release from rat mast cells in vitro.

3 Disodium cromoglycate administered intravenously to rats inhibited cutaneous anaphylaxis. Disodium cromoglycate administered intraperitoneally to rats inhibited the release of histamine and, to a lesser extent, SRS-A in the peritoneum. It was an effective but short-acting inhibitor of histamine release from rat mast cells in vitro.

4 Salbutamol was a potent inhibitor of the anaphylactic release of histamine and SRS-A from fragments of human lung.

5 Disodium cromoglycate was a weak inhibitor of the anaphylactic release of histamine and SRS-A from fragments of human lung. The inhibition was variable and not dose-related.

6 The concentration of salbutamol required to inhibit anaphylaxis in human lung is of the same order as that required to relax human bronchial muscle. It is suggested that salbutamol may be more effective in allergic asthma if given in a prophylactic regimen.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. D., Seale J. P., Rozea P., Bandler L., Theobald G., Lindsay D. A. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis. 1976 Sep;114(3):493–500. doi: 10.1164/arrd.1976.114.3.493. [DOI] [PubMed] [Google Scholar]
  2. Assem E. S., Mongar J. L. Inhibition of allergic reactions in man and other species by cromoglycate. Int Arch Allergy Appl Immunol. 1970;38(1):68–77. doi: 10.1159/000230260. [DOI] [PubMed] [Google Scholar]
  3. Assem E. S., Schild H. O. Inhibition of the anaphylactic mechanism by sympathomimetic amines. Int Arch Allergy Appl Immunol. 1971;40(4-5):576–589. doi: 10.1159/000230439. [DOI] [PubMed] [Google Scholar]
  4. Austen K. F., Orange R. P. Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis. 1975 Sep;112(3):423–436. doi: 10.1164/arrd.1975.112.3.423. [DOI] [PubMed] [Google Scholar]
  5. Austen K. F. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue. Fed Proc. 1974 Nov;33(11):2256–2262. [PubMed] [Google Scholar]
  6. Bach M. K., Brashler J. R. Ionophore A 23187-induced production of slow reacting substance of anaphylaxis (SRS-A) by rat peritoneal cells in vitro: evidence for production by mononuclear cells. J Immunol. 1978 Mar;120(3):998–1005. [PubMed] [Google Scholar]
  7. Brittain R. T., Jack D., Ritchie A. C. Recent beta-adrenoreceptor stimulants. Adv Drug Res. 1970;5:197–253. [PubMed] [Google Scholar]
  8. Collier H. O. Endogenous broncho-active substances and their antagonism. Adv Drug Res. 1970;5:95–107. [PubMed] [Google Scholar]
  9. Cox J. S. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug. Br J Dis Chest. 1971 Oct;65(4):189–204. doi: 10.1016/0007-0971(71)90028-3. [DOI] [PubMed] [Google Scholar]
  10. ELLIOTT D. F., HORTON E. W., LEWIS G. P. Actions of pure bradykinin. J Physiol. 1960 Oct;153:473–480. doi: 10.1113/jphysiol.1960.sp006548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ferris L., Anderson S. D., Temple D. M. Histamine release in exercise-induced asthma. Br Med J. 1978 Jun 24;1(6128):1697–1697. doi: 10.1136/bmj.1.6128.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fullarton J., Martin L. E., Vardey C. Studies on the inhibition of cellular anaphylaxis. Int Arch Allergy Appl Immunol. 1973;45(1):84–86. doi: 10.1159/000231007. [DOI] [PubMed] [Google Scholar]
  13. Goth A., Johnson A. R. Current concepts on the secretory function of mast cells. Life Sci. 1975 Apr 15;16(8):1201–1213. doi: 10.1016/0024-3205(75)90305-7. [DOI] [PubMed] [Google Scholar]
  14. Hedges A., Turner P. Beta-receptors in human isolated smooth muscle. Br J Pharmacol. 1969 Oct;37(2):547P–548P. [PMC free article] [PubMed] [Google Scholar]
  15. Jackson D. M., Richards I. M. The effects of sodium cromoglycate on histamine aerosol-induced reflex bronchoconstriction in the anaesthetized dog. Br J Pharmacol. 1977 Oct;61(2):257–262. doi: 10.1111/j.1476-5381.1977.tb08413.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kaley G., Weiner R. Prostaglandin E-1: a potential mediator of the inflammatory response. Ann N Y Acad Sci. 1971 Apr 30;180:338–350. doi: 10.1111/j.1749-6632.1971.tb53203.x. [DOI] [PubMed] [Google Scholar]
  17. Kaliner M., Austen K. F. A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue. J Exp Med. 1973 Nov 1;138(5):1077–1094. doi: 10.1084/jem.138.5.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kay A. B., Austen K. F. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol. 1971 Sep;107(3):899–902. [PubMed] [Google Scholar]
  19. Kerr J. W., Govindaraj M., Patel K. R. Effect of alpha-receptor blocking drugs and disodium cromoglyate on histamine hypersensitivity in bronchial asthma. Br Med J. 1970 Apr 18;2(5702):139–141. doi: 10.1136/bmj.2.5702.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kusner E. J., Dubnick B., Herzig D. J. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells. J Pharmacol Exp Ther. 1973 Jan;184(1):41–46. [PubMed] [Google Scholar]
  21. Lewis R. A., Goetzl E. J., Wasserman S. I., Valone F. H., Rubin R. H., Austen K. F. The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol. 1975 Jan;114(1 Pt 1):87–92. [PubMed] [Google Scholar]
  22. Martin L. E. Inhibition of cellular anaphylaxis by beta-stimulants. Postgrad Med J. 1971 Mar;47(Suppl):26–30. [PubMed] [Google Scholar]
  23. Moncada S., Ferreira S. H., Vane J. R. Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature. 1973 Nov 23;246(5430):217–219. doi: 10.1038/246217a0. [DOI] [PubMed] [Google Scholar]
  24. Morr H. Effect of disodium cromoglycate (Intal) on antigen-induced histamine release from passively sensitized human lung in vitro. Lung. 1978;155(1):33–38. doi: 10.1007/BF02730678. [DOI] [PubMed] [Google Scholar]
  25. Orange R. P., Austen K. F. Slow reacting substance of anaphylaxis. Adv Immunol. 1969;10:105–144. doi: 10.1016/s0065-2776(08)60416-2. [DOI] [PubMed] [Google Scholar]
  26. Orange R. P., Stechschulte D. J., Austen K. F. Cellular mechanisms involved in the release of slow reacting substance of anaphylaxis. Fed Proc. 1969 Sep-Oct;28(5):1710–1715. [PubMed] [Google Scholar]
  27. Piper P. J., Walker J. L. The release of spasmogenic substances from human chopped lung tissue and its inhibition. Br J Pharmacol. 1973 Feb;47(2):291–304. doi: 10.1111/j.1476-5381.1973.tb08327.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sharpe T. J., Ross J. W., Spicer B. A. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro. Agents Actions. 1978 Apr;8(3):199–202. doi: 10.1007/BF01966603. [DOI] [PubMed] [Google Scholar]
  29. Sheard P., Blair A. M. Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung. Int Arch Allergy Appl Immunol. 1970;38(2):217–224. [PubMed] [Google Scholar]
  30. Smith A. P., Cuthbert M. F. Prostaglandins and resistance to beta adrenoceptor stimulants. Br Med J. 1972 Apr 15;2(5806):166–166. doi: 10.1136/bmj.2.5806.166-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Strandberg K., Mathé A. A., Yen S. S. Release of histamine and formation of prostaglandins in human lung tissue and rat mast cells. Int Arch Allergy Appl Immunol. 1977;53(6):520–529. doi: 10.1159/000231794. [DOI] [PubMed] [Google Scholar]
  32. Sullivan T. J., Parker K. L., Eisen S. A., Parker C. W. Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J Immunol. 1975 May;114(5):1480–1485. [PubMed] [Google Scholar]
  33. Svedmyr N., Thiringer G. The effects of salbutamol and isoprenaline on beta-receptors in patients with chronic obstructive lung disease. Postgrad Med J. 1971 Mar;47(Suppl):44–46. doi: 10.1136/pgmj.47.543.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tauber A. I., Kaliner M., Stechschulte D. J., Austen K. F. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine. J Immunol. 1973 Jul;111(1):27–32. [PubMed] [Google Scholar]
  35. Thomson D. S., Evans D. P. Inhibition of immediate hypersensitivity reactions by disodium cromoglycate. Clin Exp Immunol. 1973 Apr;13(4):537–544. [PMC free article] [PubMed] [Google Scholar]
  36. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 Nov 23;246(5430):215–217. doi: 10.1038/246215a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES